Level C· Early human research exploring benefitsProspective StudyEurope PMCOpen access

Breast Fat Necrosis

Genova R., Garza RF.

Prospective Study on Scar, published in (2026) — summary generated from the PubMed abstract.

Open my reading list
Level C· Early human research exploring benefitsEvidence level of this study

Early human evidence such as case series or small samples is exploring possible benefits.

  • Level A · Stronger Clinical Evidence
  • Level B · Emerging clinical evidence with positive signals
  • Level C · Early human research exploring benefits
  • Level D · Scientific groundwork from lab and animal studies
  • Emerging · Emerging topic under active research
Read the A–D evidence level guide

This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.

Study type
Prospective Study
Journal
(2026)
Reported sample size
—
Source database
Europe PMC
PMID
31194348

Abstract (original English)

Breast fat necrosis is nonviable adipose cells from injured or ischemic breast tissue that is replaced with scar tissue and presents as a palpable nodule. Breast fat necrosis has various etiologies and implications; therefore, a careful patient history is imperative to properly evaluate the patient. The most common etiology of fat necrosis is recent breast surgery; however, in non-operative patients, cancer or mechanical trauma to the breast tissue is often the culprit. Breast fat necrosis can be confusing on breast imaging with malignancy (it can mimic malignancy on radiologic studies, as well as clinical presentation). It can also be cosmetically undesirable. In this article, we will focus on breast fat necrosis in the surgical patient. Anatomy Three structures comprise the breast: skin, subcutaneous tissue, and breast tissue. The breast tissue contains both epithelial and stromal elements, the latter being both adipose and fibrous connective tissue. Stromal elements are responsible for the majority of breast volume during the non-lactating state. The majority of the blood supply to the breast comes from the internal mammary artery perforators and the minority from the lateral thoracic artery perforators. This factor is essential, especially during breast reduction and/or reconstruction, where transection of vessels and subsequent relative ischemia can lead to breast fat necr

What this study does not prove

  • • This study does not prove SVF is an approved treatment or a replacement for standard care.

Evidence level

Early human evidence such as case series or small samples is exploring possible benefits.

How we grade evidence

Browse all related research

Filter the research library by this study's title keywords, author, or publication year.

Related research